Achieving appropriate model transparency: challenges and potential solutions for making value‑based decisions in the United States

5 September 2019 - Transparency in decision modeling remains a topic of rigorous debate among healthcare stakeholders, given tensions between the ...

Read more →

What is the value of market-wide health care price transparency?

5 September 2019 - A primary driver of high spending in the US health care system, relative to other countries, ...

Read more →

Capital Rx to inject transparency in prescription drug prices

4 September 2019 - In recent years, the pharmacy benefits management industry's pricing practices have been under intense scrutiny by ...

Read more →

Time for FDA to release complete responses letters? Debate reignites.

23 August 2019 - The idea of the US FDA releasing complete response letters resurfaced this week as Sarepta Therapeutics ...

Read more →

Appealing court ruling, Trump administration renews fight to require drug prices in TV ads

21 August 2019 - The Trump administration isn’t giving up the fight to require drug makers include their sticker prices ...

Read more →

Extension to feedback for public consultation - standardised redactions of PBAC Public Summary Documents

19 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers and ...

Read more →

Lack of transparency hampers cancer drug debate

19 August 2019 - The current debate raging over cancer drug funding is emotional, and the different agenda of lobby ...

Read more →

Insurers snooping in our health records

9 August 2019 - Life insurers have trawled through the medical records of 150,000 Australians in an attempt to deny ...

Read more →

Public consultation – standardised redactions of Public Summary Documents

2 August 2019 - On 30 July 2019, the Department of Health held an information forum to provide industry, consumers ...

Read more →

Proposal to enhance the transparency of CADTH’s review reports and recommendations

31 July 2019 - CADTH is committed to increasing the transparency of its health technology assessment processes.  ...

Read more →

CMS announces landmark price transparency proposals that benefit consumers

29 July 2019 - Additional proposed rules advance agency’s patients over paperwork and meaningful measures initiatives, strengthen quality incentives, and ...

Read more →

2019 October price disclosure cycle - indicative prices

22 July 2019 - Indicative 1 October 2019 prices resulting from the 2019 October cycle of price disclosure have now been ...

Read more →

A Supreme Court ruling may have made it harder to get some info from the FDA

9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...

Read more →

Will transparent pricing make America’s health care cheaper?

29 June 2019 - A new executive order requires hospitals and insurers to disclose their negotiated prices. ...

Read more →

Drug price TV ad rule will cause consumer confusion, drug makers argue

2 July 2019 - Three drug makers on Monday urged a federal judge to block a new Trump administration rule ...

Read more →